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Abstract mRNA levels of the ob gene product, leptin, were 
investigated by quantitative competitive RT-PCR in a mouse cell 
line (3T3-L1) which can be induced to differentiate into adi- 
pocytes. During conversion to fat cells, the level of leptin mRNA 
increased several-fold and in parallel to that for typical adipocyte 
markers like lipoprotein lipase, adipsin and glycerophosphate 
dehydrogenase. Leptin transcription, however, did not correlate 
with the size of the adipocytes measured as total triglycerides. On 
the other hand, mRNA levels for leptin in fully differentiated 
adipocytes were increased 2-3 fold by insulin. In contrast, free 
fatty acids exerted a concentration-dependent inhibition of leptin 
transcription while the corticosteroid examethasone and an ele- 
vation of intracellular cAMP displayed only marginal inhibitory 
effects on leptin mRNA levels. 
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1. Introduction 
The ob gene has recently been cloned and shown to encode 
for a 167-amino acid protein, leptin, which is secreted exclu- 
sively from the adipocytes of white fat [1-5]. Leptin has been 
shown to lower body weight by restraining appetite [5-8] and 
by altering metabolic processes [6]. The hypothalamus seems 
to be a target issue for the hormone, since injections of leptin 
into the intracerebral ventricle lead in mice to a reduction of 
food intake [7]. A defective ob gene promotor or a nonsense 
mutation within the coding region are believed to be the cause 
of obesity in the ob/ob mouse [1]. Although the mechanism of 
action of leptin has not been elucidated, this peptide may be the 
long sought after satiety factor eleased in the periphery (i.e. the 
adipocytes) to regulate long-term body weight [9]. In this 
lipostatic theory of body weight maintenance, as body fat in- 
creases more leptin is secreted, thereby bringing the fat mass 
back to a certain normal 'set point'. In this regard, leptin 
mRNA levels have been studied in rats with obesity secondary 
to ventromedial hypothalamic lesions and increase in parallel 
with body weight [10,11], fulfilling one of the requirement of
this regulatory system. Also in humans, it has recently been 
shown that leptin mRNA levels in white adipocytes increase or 
decrease in parallel with the body mass index [3,12]. Although 
believed to be a long-term regulator of body weight, increasing 
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evidence suggests that leptin may also form part of a short-term 
regulatory system to maintain body weight since ob mRNA 
levels are rapidly influenced by food intake and cold [13]. 
Little is known concerning the control of leptin expression. 
Changes in metabolism during weight loss and gain are associ- 
ated with alterations in the secretion of many hormones and to 
changes in the plasma concentration f critical metabolites. To 
investigate the control of leptin mRNA levels, differentiated 
mouse adipocytes maintained in culture were studied with the 
aim of evaluating whether two hormones intimately involved 
in fat metabolism, insulin and corticosteroids a  well as free 
fatty acids (FFA) contribute to the regulation of leptin mRNA 
levels in fat cells. 
2. Materials and methods 
2.1. Differentiation of 3T3-L1 cells, and mRNA isolation 
Mouse 3T3-LI cells were maintained as subconfluent cultures in 
Dulbecco's minimal essential medium (MEM 2052)/5% FCS. Thereaf- 
ter, the cells were grown to confluency in 6-well plates. To induce 
adipocyte conversion, the medium was replaced by Dulbecco's modi- 
fied Eagle's medium (DMEM)/10% FCS supplemented with 10/lg/ml 
insulin, 0.5 mM 3-isobutyl-l-methylxanthine (IBMX) and 0.6/dM dex- 
amethasone. After 2 days, the hormonal cocktail was removed and cells 
were maintained in DMEM/10% FCS for the indicated time (as out- 
lined in section 3). Overconfluent and time-matched 3T3-L1 preadi- 
pocytes did not show cytoplasmic triacylglycerol accumulation ver a 
period of 16 days. 
mRNA was isolated using the Quick Prep Micro mRNA purification 
kit (Pharmacia Biotech, Uppsala, Sweden) according to the manufac- 
turer's instructions, except that ~5 x 10 ~ cells were extracted in0.6 ml 
lysis buffer (4 M urea, 100 mM HEPES-KOH pH 7.5, 180 mM NaCI, 
1% SDS, 5 mM DTT and 400/lg/ml proteinase K), homogenized 
shortly with a Polytron PT1200 tissue homogenizer and incubated at 
56°C for 30 rain. 
2.2. Reverse transcription and quantitative polymerase chain reaction 
(PCR) 
First-strand cDNA synthesis was performed using mRNA derived 
from ~4 × 103 cells for each reverse transcription (RT) reaction. 25 pmol 
of random hexamers were hybridized by incubation for 10 min at 25°C 
and extended for 30 min at 42°C in the presence of25 U of Superscript 
H reverse transcriptase (Life Technologies, MD) in PCR buffer (10 mM 
Tris-HC1 pH 8.3, 50 mM KC1) containing 5mM MgCIz, 1 mM each 
dNTP (deoxynucleotide triphosphate) and supplemented with 8.4 U of 
RNasin (Promega, Madison, WI) in a total volume of 8.5 /tl. The 
resulting cDNA was used irectly for PCR amplification without fur- 
ther purification. PCR was carried out with Taq DNA polymerase (Life 
Technologies) using 10 pmol of each sense and antisense primer in 45 
cycles of 94°C, 65°C, 30 s each and 72°C for 1 rain in PCR buffer 
containing 2 mM MgCI2 in a total volume of 50 pl. Oligonucleotide 
primer pairs specific for the following mouse genes were used: fl- 
actin (5'-TGACCCAGATCATGTTTGAGACC-3'/5'-CCATACCC- 
AAGAAGGAA GGC-3'), glycerophosphate dehydrogenase (GPDH) 
(5'-GAATTCATCC-GCTGTCTGC-3'/5'-CTTTCCTGTGGCTG-A- 
AGTGC-3'), lipoprotein lipase (LPL) (5'-ACTCA-TCTCCG-CCAT- 
GCC-3'/5'-CCAGCTTTCTCCTAGCAAGG-3'), adipsin (5'-CTGC- 
TGGACGAGCAGTGG-3'/5'-GATGACACTCGGGTA-TAGACG- 
C-3") and leptin ( 5'-GTGCC-TATCCAGAAAGTCCAG-3'/5'- 
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TCAGCATTCAGGGCTAACA TC-3'). The corresponding heter- 
ologous tandardcompetitively withthe target cDNA, were generated 
as described previously [14]. The PCR products were separated on 
agarose gels, stained with ethidium bromide and recorded using the 
Cybertech CS system. The ratio of the signal generated from the defined 
amount of heterologous template to target cDNA was quantified using 
the Image Processing program Win Cam 2.1. To validate the method 
of quantitation, measurements of template dilutions (standard cDNA 
and target mRNA) were carried out basically as suggested by Raey- 
maekers [15]. It is possible that a factor present in particular mRNA 
preparations (i.e. from control or fully differentiated cells) might affect 
the outcome of the RT-PCR reactions and thus would prevent any 
meaningful comparison between the samples. Therefore, mRNA prep- 
arations from control and fully differentiated a ipocytes were mixed at 
various ratios and the levels of target mRNAs, as determined by com- 
petitive RT-PCR, were shown to match exactly the values expected 
from the individual mRNA preparations. 
2.3. Determination of the cellular triglyceride content 
Differentiated 3T3-LI adipocytes were harvested in PBS supple- 
mented with 0.1% SDS and lysed by a short sonication step. Triglyc- 
eride measurements were based on the ethoxide transesterification of 
triglycerides and subsequent color development with acetylacetone as 
previously described [16]. A Titertek Multiskan MC (Eflab, Helsinki, 
Finland) was used for photometric readings. 
2.4. Data analysis 
Results are expressed as mean + S.E.M. The value n represents he 
number of independent cell culture wells. Between group comparison 
was by two-tailed unpaired Student's t test. The significance was de- 
fined as a probability of equal or less than 0.05. 
3. Results 
The expression of leptin mRNA was studied during the 
conversion of 3T3-L1 cells to adipocytes. Differentiation of the 
cells was induced by supplementing the culture medium with 
IBMX, dexamethasone and insulin for 2 days. The level of 
leptin mRNA was analysed at various time points by heterolo- 
gous competitive RT-PCR as shown in Fig. 1 (left panel) and 
compared with that of other typical adipocyte markers, such 
as LPL, GPDH and adipsin. Quantitation was obtained by 
calculating the ratio of the specific signal to that of the corre- 
sponding standard. Normalization was achieved after correc- 
tion for the corresponding levels offl-actin mRNA in the same 
sample. Expression of LPL, GPDH and adipsin was found to 
increase gradually, reaching a maximum ~ 7-9 days after induc- 
tion (Fig. 1, right panel). The increase in adipsin mRNA was 
slightly delayed, as expected for a late marker of mature adi- 
pocytes. The expression of leptin mRNA was also stimulated 
after conversion of 3T3-L 1 cells to adipocytes. Curiously, leptin 
mRNA levels fell to control evels after removal of the differen- 
tiation mixture on the 2nd day after induction (Fig. 1). There- 
after, leptin mRNA increased gradually again to reach maxi- 
mum levels after about a week, in a manner similar to the level 
of other adipocyte markers. The heterologous competitive 
RT-PCR procedure also allows an estimation of the relative quan- 
tities of mRNA encoding for the various genes of interest. 
Typically, maximal evels of mRNA for GPDH were in the 
range of those encoding for #-actin whereas those for adipsin 
and LPL were ~5 x higher. Conversely, maximal levels ofleptin 
mRNA were more than 100 times less abundant. 
Lipid deposits inside the differentiated adipocytes became 
visible within the first 34  days after induction and were well- 
developed after 7 days. Thereafter, the size of the cells kept 
enlarging and at day 16 the cytosol was filled with extremely 
large fat droplets. As an indication of the size of the fat depots, 
total triglyceride content is presented in Fig. 2. The quantity of 
triglycerides at day 16 was 6-fold higher than at day 6. Leptin 
mRNA, on the other hand, had the tendency to decrease after 
day 6 (Fig. 2). 
The peculiarity of the pattern of leptin expression in the first 
phase of cellular conversion to adipocytes prompted the inves- 
tigation of the effect of some of the individual components of 
the differentiation cocktail on fully differentiated 3T3-L1 adi- 
pocytes (i.e. 1 week after induction). Addition of the phospho- 
diesterase inhibitor IBMX (0.5 raM) to the cells caused a minor 
decrease of leptin mRNA level, which, however, did not reach 
statistical significance (Fig. 3). Dexamethasone induced a mar- 
ginal inhibition of leptin expression. The inhibition was neither 
concentration-dependent nor selective for leptin mRNA. The 
expression of adipsin, the other marker for mature adipocytes, 
was inhibited similarly by the corticosteroid (Fig. 3). Insulin, 
on the other hand, increased leptin mRNA levels 2-3 fold 
above baseline ven at the lowest concentration tested (10 nM). 
Adipsin mRNA levels were only marginally affected by insulin 
even at the highest concentration of I #M. FFA are known to 
regulate the expression level of various enzymes involved in 
fatty acid metabolism. The effect of 2-bromopalmitate, a non- 
metabolizable fatty acid, on the expression of leptin is also 
presented in Fig. 3. This compound was found to strongly 
reduce the mRNA levels of leptin while adipsin expression was 
minimally affected. 
4. Discussion 
The lipostatic hypothesis postulates that appetite is con- 
trolled by a negative feedback mechanism, e.g. a satiety factor 
released from adipose tissue [9]. To fulfill this role, circulating 
leptin levels should be proportional to the total fat mass. Sev- 
eral studies have indeed found that the expression of leptin 
mRNA in various animal models of obesity [4,7,10,11] and also 
in obese humans [3,12] correlates well with body mass index. 
Since in obesity, the increased size of the fat mass is partially 
due to an enlargement of existing adipocytes rather than to 
proliferation or to the recruitment of new fat cells, a direct link 
between the size of adipocytes and the expression of leptin has 
--4 
Fig. 1. mRNA levels of adipocyte markers during differentiation. 3T3-L1 cells were cultured untill confluent (day 0) and than differentiation was 
induced by adding a cocktail supplemented with IBMX, insulin and dexamethasone for 2 days. After differentiation, adipocytes were kept in culture 
in DMEM medium supplemented with 10% calf serum. Poly mRNA was isolated from cell samples at various times during culture. Semiquantification 
of the mRNA levels of the various adipocyte markers (LPL, GPDH, adipsin and leptin) and offl-actin was obtained by competitive RT-PCR as 
described in section 2. The cDNAs were amplified with specific primers in the presence of known amounts of the respectives standards. Upper panel: 
the PCR products obtained in a typical experiment were separated on 0.8% agarose gel. S and T correspond to the bands of the standard and of 
the target, respectively. Lower panel: semiquantitation of the various mRNAs was carried out for each cell sample and normalized to the amount 
offl-actin mRNA. Maximal evels of expression were set to 100%. The figure shows the mean + S.E.M., n = 3. A significant change over t = 0 is 
indicated by *. 
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Fig. 2. Determination of total triglycerides and of leptin mRNA in 
cultured 3T3-L1 cells after differentiation. Fully differentiated 3T3-L1 
adipocytes were harvested atvarious times and split for the colorimetric 
determination f triglycerides and for the isolation of mRNA. Leptin 
mRNA was quantified by heterologous competitive RT-PCR (see sec- 
tion 2) and normalized to the corresponding fl-actin levels. Data are 
given as the mean + S.E.M., n = 3. A significant change over control 
value is indicated by * 
been postulated, Indeed, within individuals preliminary evi- 
dence suggests that the level ofleptin mRNA is higher in larger 
than in smaller adipocytes [12]. Alternatively, leptin production 
by white fat could be regulated by changes in humoral factors 
or substrate flux rather than by the actual size of the adipocytes. 
Using differentiated mouse adipocytes in culture, the present 
study has investigated the role of cell size and of selected 
hormones and metabolites, whose concentration is known to 
be altered in obese animals, on the regulation of leptin expres- 
sion. 
It remains a controversial issue whether preadipocytes can 
express leptin. For example, preadipocytes i olated from 
human fat pads express leptin mRNA whereas mouse preadi- 
pocytes do not, even after partial differentiation [12]. In 3T3- 
F442A cells, a mouse cell line which can also be induced to store 
lipid, leptin mRNA levels are undetectable b fore full differen- 
tiation into adipocytes [11]. In contrast, the present studies 
demonstrate hat in another mouse cell line (3T3-LI) leptin 
mRNA is detectable before differentiation. These observations 
suggest hat expression of leptin by cells other than mature 
adipocytes depends on various factors, which include the cell 
system and the animal species under investigation. 
There is substantial but indirect evidence that insulin regu- 
lates leptin expression in white adipose tissue. In situations 
where insulin secretion is increased, e.g. following a meal or 
after chronic central neuropeptide-Y (NPY) infusion, adi- 
pocyte leptin mRNA levels increase in parallel [13,17]. The 
stimulatory effect of NPY on leptin mRNA persists even when 
NPY-induced hyperphagia s compensated for by pair-feeding 
[17]. These observations strongly suggest that it is not hyper- 
phagia or the consumption of a meal which correlates with in- 
creased leptin expression but rather the resulting elevation of 
circulating insulin. In support of this hypothesis, it has been 
shown that fasting reduces both the circulating insulin and 
leptin mRNA levels [13]. The present studies extend these ob- 
servations to provide direct evidence that the level of leptin 
mRNA in fully differentiated 3T3-Ll adipocytes i under the 
control of insulin. The stimulatory effect of insulin is quite 
pronounced and selective for leptin, since the mRNA for ad- 
ipsin, another substance secreted by the adipocytes, is barely 
affected (Fig. 3). Our experiments, therefore, support he con- 
tention that rapid changes in circulating insulin might be re- 
sponsible, at least in part, for the changes in leptin mRNA 
levels observed uring the fasting-eating cycle. Moreover, the 
elevated leptin expression observed in various obesity models 
1.5 ~ TG (mg/well) A leptin mRNA 
, i i lO 
1.o- ,-, ~: 
-6 pB. 
-4 . ' .N  
0.5- 5" 
o.o ; 1'o 1'2 1'4 1'6 o 
days 
Fig. 3. Regulation of leptin and adipsin expression i fully differenti- 
ated 3T3-L1 adipocytes. Fully differentiated 3T3-L1 adipocytes were 
incubated for 24 h in the presence ofthe given concentrations of dexa- 
methasone, 2-bromopalmitate (FFA), IBMX and insulin, mRNA levels 
of leptin and adipsin were determined by quantitative RT-PCR, nor- 
malized for the fl-actin amounts in the same samples and presented as
percentage of the mRNA amount of untreated control cells. Data are 
given as the mean + S.E.M., n = 3. A significant change over day 6 is 
indicated by a * 
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could simply reflect the fact that these animals are hyperin- 
sulinemic. In a recent publication, De Vos et al. [18] provided 
convincing evidence that the inhibitory effect of pharmacologi- 
cal concentrations of corticosteroids on food intake and the 
consequent loss of body weight are mediated by an increase of 
adipocyte leptin mRNA. The present experiments using iso- 
lated adipocytes in culture, however, do not demonstrate a 
direct stimulatory effect of the corticosteroid dexamethasone 
on leptin mRNA levels (Fig. 3). It is likely, therefore, that the 
rapid elevation of insulin induced by the high doses of cortico- 
steroid, could have accounted for the stimulatory effect on leptin 
mRNA observed in vivo [13]. 
FFA are also obvious candidates for a possible regulatory 
signal controlling adipocyte leptin production. Prior studies 
conducted using Ob1771 preadipocytes have shown FFA to 
upregulate the expression of terminal differentiation-related 
genes and genes involved in fatty acid metabolism [19]. The 
effect of FFA on transcription is normally mediated by the 
interaction with peroxisome proliferator-activated r ceptors 
(PPAR), which are nuclear receptors of the steroid/thyroid 
hormone superfamily. Our studies indicate that the level of 
intracellular FFA could play a crucial role also in the downreg- 
ulation of leptin expression. In support of this contention are 
prior studies showing that most conditions known to inhibit 
leptin synthesis, such as starvation and cold exposure [13], are 
accompanied by increased lipolysis and elevated concentrations 
of intracellular FFA. Similarly, a reduction of cytosolic FFA 
induced by the antilipolytic action of insulin could mediate the 
stimulatory effect of the hormone on leptin transcription in 
adipocytes. 
It has been suggested that the fat cell size may control, via 
a hitherto unknown mechanism, the quantities of leptin pro- 
duced [1,10]. However, the results of the present study do not 
support his contention since the amount of leptin mRNA did 
not correlate with the size of fully differentiated 3T3-L1 adi- 
pocytes (Fig. 2). The possibility should be considered, however, 
that the isolated cell system we used as a model might not be 
truely representative of fat cell hypertrophy in the intact ani- 
mal. 
In conclusion, the observations presented in this study sug- 
gest that insulin acts directly on adipocytes to increase the 
mRNA levels while FFA, on the other hand, are inhibitory to 
leptin expression. Extending these observations to the whole 
animal may mean that the plasma concentration of insulin and 
FFA, which reflect he metabolic state of the adipocytes, could 
play a central role in leptin expression. Finally, the extent of 
leptin mRNA expression i fat tissue reflects rather the number 
than the size composition of fat cells. 
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